 |
|
|
|
 |
|
|
 Print version |  PDF version |  Recommend company
|
| Raven biotechnologies, inc. |
One Corporate Drive
94080 San Francisco, CA
United States of America
|
|
Portrait
Raven biotechnologies, inc. () is a privately held biotechnology company focused on the development of monoclonal antibody therapeutics for treating cancer. Raven’s lead product candidate, RAV12, targets adenocarcinomas and is in clinical development for the treatment of gastrointestinal and other cancers. Raven’s discovery process simultaneously identifies cell-surface drug targets and the antibody therapeutics to regulate them.
To date Raven has identified multiple candidate therapeutic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast, and ovarian cancer.
Industrial Sectors
Additional information
Raven biotechnologies, inc.
San Francisco, CA, United States of America
News
|
|
|
|
|
|
Top
